NASDAQ · Biotechnology

Structure Therapeutics Inc. American Depositary Shares (GPCR)

$21.87 -0.32%
Add alert See all oversold stocks →
27 Oversold Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$52.38-58.25%

Company profile

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. The company is headquartered in South San Francisco, California.

SectorHealthcare
IndustryBiotechnology
Market cap$1.71B
P/E ratioNone
EPS$-3.03
Beta-1.368
Dividend yield0.00%
52-week high$94.90
52-week low$22.15

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 41 VRTX Vertex Pharmaceuticals Inc RSI 68 CRSP CRISPR Therapeutics AG RSI 48 IOVA Iovance Biotherapeutics Inc RSI 30 NTLA Intellia Therapeutics Inc RSI 53 SRPT Sarepta Therapeutics Inc RSI 51 NVAX Novavax Inc RSI 45 GHRS GH Research PLC RSI 48 RXRX Recursion Pharmaceuticals Inc - Class A RSI 53 AUPH Aurinia Pharmaceuticals Inc RSI 49
30 days of PRO Unlimited free, no card

RSI alerts for GPCR

An email when GPCR closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 9:57 PM EDT